Ombitasvir/Paritaprevir/Ritonavir plus Dasabuvir are Safety and Eficacy for Treating HCV GT1 and 4 Infection in Patients with Severe Renal Impairment or End-Stage Renal Disease: A Mulcicenter ExperienceRozas Gomez, I. Fernández, M.D. Pérez Valderas et al.|Journal of Hepatology|2016Cited by 8